Purchase Order 75N91023P00891
Award Date
9/28/23
Potential Completion Date
12/27/23
Potential Value
$14K
Federal Agency
National Cancer Institute
Awardee
Becton, Dickinson And Company
Ultimate Awardee
Becton, Dickinson & Co
NAICS Category
811310 - Commercial and Industrial Machinery and Equipment (except Automotive and Electronic) Repair and Maintenance
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Bethesda, MD 20892, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Department of Health and Human Services' National Institutes of Health National Cancer Institute awarded a $16,761.96 firm fixed price purchase order to Becton, Dickinson and Company for maintenance services with a period of performance through August 2024. As the prime contractor, Becton, Dickinson and Company will provide maintenance under this order through its BD Biosciences division located in Rockville, Maryland. No set-aside designation was used for this award to support the...
Becton, Dickinson and Company BD Biosciences, Systems and Reagents Division will provide maintenance services to the National Cancer Institute, a component of the Department of Health and Human Services' National Institutes of Health, under a one-year, firm fixed-price purchase order valued at $24,192.00. The contract supports maintenance of equipment and reagents at the National Cancer Institute's campus in Bethesda, Maryland. No set-aside designation or subcontractors were indicated. Becton...
Becton, Dickinson and Company (BD) has been awarded a firm fixed price purchase order by the National Institutes of Health National Cancer Institute for $10,864.80. The contract calls for servicing an instrument used by approximately 75 personnel at the agency to conduct experiments involving costly reagents, animals, and extensive labor hours. Performance will take place in Bethesda, Maryland through April 2024. No set-aside designation was applied. This award is likely associated with...
This is a federal contract award to Becton, Dickinson and Company (BD) by the National Cancer Institute (NCI), a component of the National Institutes of Health (NIH), for maintenance services on government-owned Becton Dickinson instrumentation. The $141,480.00 firm fixed-price purchase order supports the work of the NCI's Center for Cancer Research, Experimental Immunology Branch. The contract has no set-aside designation and was awarded on February 1, 2017, with a completion date of January...
The Department of Health and Human Services, National Institutes of Health, National Cancer Institute awarded a firm-fixed-price purchase order to Becton, Dickinson and Company (BD) for maintenance service on a BD LSR Fortessa SORP cytometer and associated instrumentation, in support of the Surgery Branch of the National Cancer Institute. The contract has a period of performance from August 1, 2021 to July 31, 2026 and a potential value of $123,167.40. No set-aside designation was used for...
The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a $23,468.69 delivery order contract to Becton, Dickinson and Company BD Biosciences, Systems and Reagents Division for scientific equipment. The prime contractor, Becton, Dickinson and Company BD Biosciences, will provide the equipment under a firm fixed price arrangement. Performance will take place in San Jose, California over a four month period concluding in December 2023. The award...
The Department of Health and Human Services' National Institutes of Health Clinical Center awarded an approximately $18,351 firm fixed price purchase order to Becton, Dickinson and Company BD Biosciences, Systems and Reagents Division for products and services to be delivered through August 2024. As the prime contractor, BD Biosciences will provide biological testing materials to support biomedical research activities at the NIH Clinical Center, a hospital dedicated to clinical research. No...
The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a firm fixed-price purchase order to Becton, Dickinson and Company (BD), a global medical technology company, for preventive maintenance, emergency service, support, and coverage for four government-owned BD Biosciences flow cytometry instruments. The one-year contract with four option years, valued at $148,833.48, provides for semi-annual preventive maintenance, on-site emergency repair...
The National Cancer Institute (NCI), part of the National Institutes of Health (NIH) in the Department of Health and Human Services (HHS), awarded a $38,205.50 firm fixed-price purchase order to Becton, Dickinson and Company (BD) to provide one (1) BD High Throughput Sampler in support of a government-owned BD LSRFortessa Flow Cytometer at the NCI's Center for Cancer Research. This equipment will be used by the NCI's Lymphoid Malignancies Branch. The award did not utilize a small business...
The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a firm fixed price purchase order contract valued at $12,821.67 to Becton, Dickinson And Company (BD) for the acquisition of a 5-laser SORP cell analyzer instrument. This instrument is currently being used by all members of the EIB (likely referring to an internal NIH program) to prevent disruption of ongoing research experiments. The contract has a completion date of July 1, 2024. BD is a...